Last week SwedenBIO released its pipeline report for drug development 2026. The report shows continued resilience in the Swedish pharmaceutical pipeline, despite global economic and political challenges that are shaking the industry.
We at Sirona are happy to have contributed to the report by supporting the data collection.
We thank SwedenBIO for the collaboration, and for a great report!
If you want to know more about the report, you can read here: swedenbio.se/svensk-life-science-continues-strong-in-early-research-and-innovation-shows-new-pipeline-report/
